Beclometasona [Inn-Spanish] en es it fr

Beclometasona [Inn-Spanish] Brand names, Beclometasona [Inn-Spanish] Analogs

Beclometasona [Inn-Spanish] Brand Names Mixture

  • none

Beclometasona [Inn-Spanish] Chemical_Formula


Beclometasona [Inn-Spanish] RX_link

Beclometasona [Inn-Spanish] fda sheet

Beclometasona_[Inn-Spanish] FDA

Beclometasona [Inn-Spanish] msds (material safety sheet)

Beclometasona [Inn-Spanish] Synthesis Reference

U.S. Pat. 3,312,590 (1967)

Beclometasona [Inn-Spanish] Molecular Weight

521.042 g/mol

Beclometasona [Inn-Spanish] Melting Point


Beclometasona [Inn-Spanish] H2O Solubility

49.39 mg/L

Beclometasona [Inn-Spanish] State


Beclometasona [Inn-Spanish] LogP


Beclometasona [Inn-Spanish] Dosage Forms

Oral inhalation; Nasal inhalation; Nasal spray

Beclometasona [Inn-Spanish] Indication

For the maintenance treatment of asthma as prophylactic therapy in patients 5 years of age and older

Beclometasona [Inn-Spanish] Pharmacology

Beclomethasone, a synthetic halogenated glucocorticoid with antiinflammatory and vasoconstrictive effects, is used for treating steroid-dependent asthma, allergic or nonallergic rhinitis, or recurrent nasal polyps.

Beclometasona [Inn-Spanish] Absorption

Mean peak plasma concentration was 88pg/ml at 0.5 hour

Beclometasona [Inn-Spanish] side effects and Toxicity

The acute toxicity of beclomethasone dipropionate is low. The only harmful effect that follows inhalation of large amounts of the drug over a short period of time is suppression of hypothalamic-pituitary-adrenal (HPA) function. Chronic: The excessive use of beclomethasone dipropionate over a long period could lead to adrenal suppression.

Beclometasona [Inn-Spanish] Patient Information

Beclometasona [Inn-Spanish] Organisms Affected

Humans and other mammals